Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Inovio Pharmaceuticals, Inc. - Common Stock (NQ:INO)

1.565 -0.045 (-2.80%)
Streaming Delayed Price Updated: 11:21 AM EST, Feb 12, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Inovio Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
Before 10 a.m. ET Tuesday, 173 stocks hit new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was Snowflake (NYSE:SNOW... 
Via Benzinga
News headline image
Earnings Scheduled For May 10, 2021 ↗
Companies Reporting Before The Bell • Revlon (NYSE:REV) is likely to report earnings for its first quarter. • Bluegreen Vacations (NYSE:BVH) is expected to report... 
Via Benzinga
News headline image
Novavax, Inovio Stocks Hammered As Covid Vaccine News Disappoints ↗
Vaccine stocks crumbled Tuesday after Novavax announced a delay and Inovio's Covid vaccine disappointed in testing. Both NVAX stock and INO stock plunged. 
Via Investor's Business Daily
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Gainers Cerecor (NASDAQ:CERC) shares rose 14.56% to $2.91 during Tuesday's pre-market session. The company's market cap stands at $281.4 million. Larimar... 
Via Benzinga
News headline image
Inovio Pharmaceuticals (INO) Q1 2021 Earnings Call Transcript ↗
INO earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Recap: Inovio Pharmaceuticals Q1 Earnings ↗
Shares of Inovio Pharmaceuticals (NASDAQ:INO) decreased in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share decreased 3.85% over... 
Via Benzinga
News headline image
Inovio's DNA COVID-19 Vaccine Candidate Triggers Immune Response In Pivotal Study ↗
Inovio Pharmaceuticals Inc (NASDAQ: INO) has announced positive data from the Phase 2 segment of its Phase 2/3 INNOVATE trial in the U.S.,... 
Via Benzinga
News headline image
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -... 
Via Benzinga
News headline image
20 Stocks Moving in Monday's Pre-Market Session ↗
Gainers Alfi, Inc. (NASDAQ: ALF) shares rose 30.3% to $4.82 in pre-market trading. The company recently appointed Ron Spears as Chief Revenue Officer. SemiLEDs Corporation (... 
Via Benzinga
News headline image
Preview: Inovio Pharmaceuticals's Earnings ↗
Inovio Pharmaceuticals (NASDAQ:INO) announces its next round of earnings this Monday, May 10. Here is Benzinga's everything-that-matters guide for this Monday's Q1 earnings... 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
On Tuesday morning, 58 companies hit new 52-week lows. Points of Interest: The largest company by market cap to set a new 52-week low was Lufax Holding (NYSE:LU).... 
Via Benzinga
News headline image
The Week Ahead In Biotech (May 9-15): Heron, Apellis FDA Decisions, Presentations and Earnings ↗
Biotech stocks came under pressure in the week ended May 7 as traders digested a slew of earnings news flow and a handful of clinical trial readouts. COVID-19 vaccine stocks came... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Split Verdict For Chemocentryx, NKarta-CRISPR In Cell Therapy Collaboration, Orphazyme's Clinical Trial Setback, 2 IPOs ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 6) GT Biopharma, Inc. (NASDAQ:... 
Via Benzinga
News headline image
The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 4) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
News headline image
Cramer Weighs In On Coinbase, Kellogg And More ↗
Jim Cramer said on CNBC's "Mad Money Lightning Round" that he has always felt that Ocugen Inc (NASDAQ: OCGN) is a great spec, but it's a heavily shorted stock... 
Via Benzinga
News headline image
Can Inovio Recover From Its Huge Setback? ↗
It might be able to, although it won't be easy. 
Via The Motley Fool
News headline image
Is There Any Hope for Inovio? ↗
Everything may depend on an early-stage program. 
Via The Motley Fool
News headline image
Market Briefing For Monday, Apr. 26 ↗
Nasdaq is perking up, primarily led by FANG types reporting next week (discounted). So, higher a bit near-term; then, risks. 
Via Talk Markets
News headline image
Mid-Afternoon Market Update: Nasdaq Surges 1.5%; EDAP Shares Plunge ↗
Toward the end of trading Friday, the Dow traded up 0.67% to 34,041.01 while the NASDAQ rose 1.54% to 14,031.45. The S&P also rose, gaining 1.16% to 4,182.83. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
50 Biggest Movers From Friday ↗
Gainers Sypris Solutions, Inc. (NASDAQ: SYPR) shares surged 59.1% to close at $4.47 on Friday after the company said its electronics unit has won a contract for deep space... 
Via Benzinga
News headline image
Mid-Day Market Update: Skechers Jumps On Earnings Beat; Inovio Pharmaceuticals Shares Drop ↗
Midway through trading Friday, the Dow traded up 0.52% to 33,992.56 while the NASDAQ rose 0.93% to 13,947.48. The S&P also rose, gaining 0.82% to 4,168.89. The U.S. has the... 
Via Benzinga
Topics Stocks
News headline image
32 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Sypris Solutions, Inc. (NASDAQ: SYPR) shares climbed 24.7% to $3.50 after the company said its electronics unit has won a contract for deep space program. MicroVision,... 
Via Benzinga
News headline image
Inovio Stock Collapses After U.S. Officials Pull Funding For Covid Vaccine Test ↗
Inovio said Friday the Department of Defense pulled its funding for final-phase testing of the company's Covid vaccine, prompting INO stock to collapse. 
Via Investor's Business Daily
News headline image
Why Inovio Stock Is Crashing Today ↗
The biotech just lost funding for the late-stage study of its COVID-19 vaccine candidate. 
Via The Motley Fool
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
During the morning session on Friday, 6 stocks hit new 52-week lows. Facts of Interest: The company with the largest market cap to set a new 52-week low was Quidel... 
Via Benzinga
News headline image
Mid-Morning Market Update: Markets Rise; Honeywell Beats Q1 Estimates ↗
Following the market opening Friday, the Dow traded up 0.11% to 33,852.74 while the NASDAQ rose 0.82% to 13,932.03. The S&P also rose, gaining 0.47% to 4,154.53. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
Inovio Stock Slumps After Plans To Exclude US For COVID-19 Vaccine Candidate's Global Trial ↗
Inovio Pharmaceuticals Inc (NASDAQ: INO) shares dived in the premarket in reaction to the company's plans for a predominantly ex-U.S. Phase 3 trial for... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
Gainers Jaguar Health (NASDAQ:JAGX) shares moved upwards by 11.8% to $1.61 during Friday's pre-market session. The market value of their outstanding shares is at $205.... 
Via Benzinga
News headline image
Here's the Dr. Fauci Statement That Could Mean Good News for Inovio ↗
It's all about the ultimate coronavirus vaccine. 
Via The Motley Fool
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.